Report of the 2011-2012 Standing Committee on Advocacy: The Relevance of Excellent Research: Strategies for Impacting Public Policy by Allen, David D. et al.
AACP REPORTS
Report of the 2011-2012 Standing Committee on Advocacy: The Relevance
of Excellent Research: Strategies for Impacting Public Policy
David D. Allen, Chair,a Julie Lauffenburger,b Anandi V. Law,c R. Pete Vanderveen,d and
William G. Lange
aSchool of Pharmacy, The University of Mississippi, University, MS
bEshelman School of Pharmacy, University of North Carolina at Chapel Hill, CB
cCollege of Pharmacy, Western University of Health Sciences, Pomona, CA
dSchool of Pharmacy, University of Southern California, Los Angeles, CA
eAmerican Association of Colleges of Pharmacy, Alexandria, VA
INTRODUCTION
According to the Bylaws of the American Associa-
tion of Colleges of Pharmacy (AACP), the Advocacy
Committee:
“will advise the Board of Directors on the formation of
positions on matters of public policy and on strategies
to advance those positions to the public and private
sectors on behalf of academic pharmacy.”
COMMITTEE CHARGE
President Brian Crabtree charged the 2011-2012Ad-
vocacy Committee to:
1. Examine what AACP should do to balance the
advocacy portfolio with respect to education
and science scholarship.
2. Recommend strategies for demonstrating the
value of education and science scholarship to
address the mission of the Academy in commu-
nities served by member institutions.
3. Recommend specific approaches and advocacy
strategies for consideration by AACP and mem-
ber institutions for implementing interprofes-
sional education.
TheCommitteemet in-person inOctober inArlington,
VA to discuss the charge and determine the approach to
meeting the charge. This face-to-face meeting allowed for
averywide rangingdiscussion that brought into clear focus:
1. the imbalance/disconnect in the number of
AACP policy statements relevant to science
(biomedical and translational) research com-
pared to those relevant to education research.
AACP has many more policy statements rele-
vant to science scholarship than it does policy
statements relevant to education scholarship.
2. that AACP organizational activity related to ed-
ucational research in terms of programmatic
and student assessment, student progress, pub-
lication of educational research in AJPE, is
extensive and yet there is little organizational
policy supporting this activity.
3. Possible answers to questions such as: Who is
interested in the quality of our education? Who
cares about the good education processes we
engage in? What is the value to the public of
the way we educate and the outcomes of our
education? How long does “we are teaching
you for the future” remain relevant?
4. The fact that many communities and stake-
holders do not fully understand or appreciate
the importance of either science or education
scholarship and their contributions to individual
and public health.
5. AACP members engagement in science and ed-
ucation scholarship is worthy of recognition of
its social impact.
6. The importance of moving from identifying bar-
riers to effective interprofessional education to-
ward overcoming and eliminating these barriers.
Continuing reflection by the committee resulted in
an approach that would increase the public’s appreciation
of the benefits of pharmacy education to health. Public
appreciationwould be increased by rearticulating the con-
nection between both education and science scholarship
as the foundations for continuous quality improvement
of pharmacy education. An organizational policy agenda,
broad in its application to our Academy, and focused in
its application to public policy, was developed. This pol-
icy agenda is framed within the teaching, research and
service expectations of pharmacy faculty. It establishes
the importance of:
1. teaching as the primary contribution of the
Academy to the public’s health through the
education of a pharmacist competent to work
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collaboratively and interprofessionally with
patients, caregivers and other health profes-
sionals;
2. the creation, integration and application of ed-
ucation and science scholarship as essential con-
tributors to the continuous improvement of
pharmacy education; and
3. the importance of the educational and science
scholarship and interprofessional education as
a key opportunity for addressing the public pol-
icy question of how best to reorganize our
healthcare system.
BACKGROUND
The benefit of academic pharmacy to the health of
our nation and theworld is a direct result of the teaching,
research and service of its faculty. These three compo-
nents, reflecting the mission of higher education, are
relevant and important to improving individual and
population health, improving health care processes
and delivery, and preventing further escalation of asso-
ciated costs.
Teaching is the Foundation of the Academy’s
Commitment to the Public
The primary purpose of pharmacy education is to
improve the public health through the education of a
health professional, the pharmacist, competent to meet
or exceed the public expectations of the pharmacist as
expressed in state practice acts. Pharmacy education
meets that competency expectation through a progressive
series of educational experiences guided by educational
outcomes, accreditation standards and individual institu-
tion priorities. The mission of AACP is to improve the
quality of pharmacy education so that our public contract
is met. As stated by AACP policy passed by the House of
Delegates and proposed by the Academic Affairs Com-
mittee in 2007 “The mission of pharmacy education is to
prepare graduates who provide patient-centered care that
ensures optimal medication therapy outcomes and pro-
vides a foundation for specialization in specific areas of
pharmacy practice; participation in the education of pa-
tients, other healthcare providers, and future pharmacists;
conduct of research and other scholarly activity; and pro-
vision of service and leadership to the community.”
The continual assessment and use of that assessment
for the improvement of individual faculty, courses, pro-
grams and entire curricula is essential. Support for these
activities is stated in the AACP policy “AACP supports
and encourages the implementation of on-going program
assessment processes atmember institutions for thepurpose
of enhancing the quality of educational programs and stu-
dent services approved by our House of Delegates in 2004.
This assessment process also addresses a significant public
policy discussion regarding the value of higher education
in light of continually increasing tuition and education
costs. Scholarly teaching and the study of effective educa-
tion approaches are both important contributions of our
faculty to the assurance of public health.
Proposed Policy Statement
AACP endorses the scholarship of evidence-based
education which includes but is not limited to assessment
of teaching and student learning and the integration and
application of patient and professional advocacy.
Academic pharmacy improves the public health
through its continued and persistent commitment to
research and service of its faculty.
Academic pharmacy further improves the public
health through education and science research and the
dissemination of both education and science knowledge
in the service activities of its faculty and the integration
of new education and science scholarship back into the
professional curriculum. While biomedical and science
scholarship frequently receive greater attention for their
contributions to the public, the tacit benefits of education
scholarship are not without merit since as stated above it
ensure that the education of the pharmacist is relevant to
the expectations of the public and continually improves
and evolves to meet that expectation. Meeting the public
expectation of higher education is increasingly important.
Federal legislation, most frequently through the reautho-
rization of the Higher Education Act, is influenced by
public opinion and expectations of higher education.
The National Advisory Committee on Institutional Qual-
ity and Integrity (NACIQI), the federal advisory body
authorized in the HEA to advise the Secretary of the De-
partment of Education, in a draft document released on
January 17, 2012 stated “we recognize that this is a time
of considerable focus on quality in higher education, with
emerging areas of serious concern about value, stan-
dards, outcomes, cost, transparency, and accountability.”1
AACP policy statements passed by its House ofDelegates
that support these important activities of the mission of
higher education are numerous with at least 17 research
related policy statements.2 A preponderance of policy
statements relevant to science scholarship should not
minimize the importance of education scholarship since
the latter forms the foundation of the Academy’s commit-
ment to the public and is essential for addressing the pub-
lic expectations of higher education. All three elements:
teaching, research, and service contribute to protecting
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and improving public health. Public health is best pro-
tected when there is individual faculty participation, con-
tribution and dissemination of all three elements.
Education scholarship gains a heightened impor-
tance if it is agreed that teaching and therefore education
is the foundation of the Academy’s commitment to the
public. The assimilation of evidence-based teaching ap-
proaches into the contemporary pharmacy professional
curriculum ensures that teaching provides the appropriate
competency development of the pharmacist. Attention to
continuous quality improvement of the educational expe-
rience is a public good in its assurance of professional
competency attainment and also serves another important
public good. Current public policy discussions regarding
the value of education can be addressed only through the
demonstration of a commitment to continuous quality
improvement of the educational experience. Academic
pharmacy, through the development of programs, prod-
ucts and services under the auspices of the American
Association of Colleges of Pharmacy, can effectively
demonstrate its commitment to improving the quality of
a student’s educational experience, which can be gained
at a cost that does not exceed the individual student’s
contribution to the public.
TheAmerican Journal of Pharmaceutical Education
(AJPE) is the premier journal of pharmacy education. The
purpose of AJPE “is to document and advance pharma-
ceutical education in the United States and internation-
ally.”3 In a 2005 special report published in AJPE stated,
“While there have been over 9,000 publications on assess-
ment in higher education, only slightly more than 100
address pharmacy education, and approximately half of
these were published in the Journal.”4 This information is
presented as a way to demonstrate the commitment of our
Academy to continuous improvement of pharmacy edu-
cation, the importance of disseminating education schol-
arship and the grounding of pharmacy education in
broader higher education theory.
Proposed Policy Statement
AACP endorses evidence-based education, continu-
ous quality improvement, rigorous accreditation stan-
dards and assessment.
Improving Healthcare: Making Patient-Centered,
Team-Based Care a Reality Through Education
The citizens of theUnited States contribute over $2.6
trillion annually to a healthcare system that providesmar-
ginal benefit in terms of improved health outcomes com-
pared to other industrialized nations.5,6 Our healthcare
system sustains some of the most dramatic health dis-
parities in terms of access and service delivery when
compared to similar nations. The lack of social justice
evident in our healthcare system is seen across age groups,
ethnicity, socio-economic status, education, and health
status. Like any institution in need of change how that
change should manifest itself has been debated for de-
cades. Contemporary business improvement concepts,
focusing on inputs, outputs and process, provide a frame-
work for improving our healthcare system. Consensus
brought to the fore a quality improvement approach that
would improve health (output), improve healthcare (pro-
cess) and control costs (input).
The Institute of Medicine (IOM) in its quality chasm
series coalesced those decades of debate. In its 2003 re-
port, “Health Professions Education: A Bridge to Qual-
ity,” the IOM addressed an important input requirement
by recommending that all health professionals receive an
education that allows the attainment of competence to
deliver care in a patient-centered, team-basedmanner that
was supported by informatics and to engage in quality
improvement.7 Academic pharmacy supports this compe-
tency development strategy and articulates that support
in the following policy statement passed by the House of
Delegates in 2007: “AACP endorses the competencies of
the Institute of Medicine for health professions education
and advocates that all colleges and schools of pharmacy
provide faculty and students meaningful opportunities to
engage in interprofessional education, practice and re-
search to better meet health needs of society.”
Academic pharmacy demonstrates its support for
its own policy statement through individual member in-
stitution and inter-organizational activities that may be
supported by federal programs aligned with the IOM
recommendations. The federal programs include the
health professions education programs authorized by
Title VII of the Public Health Service Act. The demon-
stration of support for efforts to improve the delivery
of healthcare through patient-centered, team-based,
informatics-supported approaches requires attention to
teaching, research and service. AACP, most recently
through The Interprofessional Education Collaborative
(IPEC), an inter-organizational activity aligned with five
other health professions education organizations, exhibits
the interest of its membership in interprofessional educa-
tion. IPEC has developed and published a document that
lists the core interprofessional competencies for collabo-
rative practice.8
Our member institutions, supported by the standards
of the Accreditation Council for Pharmacy Education,
work to ensure our students receive evidence-based, in-
terprofessional and culturally competent learning experi-
ences.9 Our faculty engage in activity that advances the
concepts of team-based care through the use of a scholarly
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approach to interprofessional education and the develop-
ment of successful practices grounded in evidence-based
higher education theory.10,11 Committee members pro-
vided examples from their own institutions as examples
that demonstrate the Academy’s commitment to contin-
ually improving the quality of pharmacy education. For
example, Western University of Health Sciences (West-
ern U) instituted an interprofessional education (IPE) cur-
riculum that includes 9 colleges within the University,
including the College of Pharmacy. The program out-
comes are that the Western U graduate will demonstrate
an understanding of other health professionals and pro-
vide and promote a team-based approach to patient care
and health care management.
Western U’s IPE curriculum is delivered as a three
phase approach that encompasses entry-level and more
advanced healthcare professions students who are engag-
ing in the clinical phase of their respective curricula.
Phase I is a case-based course where students from all
programsparticipate in an interprofessional groups.Com-
petencies for this course include communication and col-
laboration; formation of an interprofessional team; roles
and responsibilities of the professions; application of
quality of life and a culture of safety; integration of the
mission and vision of the One Health Initiative;12 and the
ethical and legal environment of healthcare. The second
phase is designed to help instill further teamwork princi-
ples especially in the asynchronous healthcare environ-
ment. The third phase is clinical where the students are
now expected to apply the principles from phase I and II
to enhance their clinical practice skills. Throughout all
phases of the curriculum students are provided with an
evidence-based teaching platform that includes material
from TeamSTEPPS, an evidence-based approach to
teamwork in healthcare that is designed to enhance per-
formance and promote patient safety.13
Initial findings from the program include strong pos-
itive attitudes toward interprofessional collaboration as
measured by surveys of students and faculty; a variety
of positive course experiences as measured by student
surveys and blogs; and higher ratings of teamwork be-
havior among students with IPE training vs. those with-
out, asmeasured during a standardized patient encounter
exercise.
The University ofMississippi School of Pharmacy is
engaged in interprofessional education (IPE) activities
on both the Oxford and Jackson (Medical Center) cam-
puses. On the Oxford campus, Department of Pharmacy
Practice faculty currently provide lectures for the School
of Nursing on topics related to diabetes, and other disci-
plines (nutrition) participate in our second professional
year Skills Laboratory. The School of Nursing (Oxford)
provides simulation lab activities for students and we are
currently exploring opportunities for nursing and phar-
macy student interactions in this environment. Discus-
sions are underway with the School of Applied Sciences
(Oxford) to determine a third discipline for participation
in IPE activities on that campus.
On the Medical Center campus, there are newly
formed institutional IPE committees on which School of
Pharmacy faculty/students are active participants. Fac-
ulty from the different Schools are collaborating to iden-
tify IPE resources and funding opportunities. Department
of Pharmacy Practice faculty on theMedical Center cam-
pus currently administer an interprofessional two-credit
hour Public Health/Preventive Medicine course with the
School of Medicine. The design of this course allows for
interaction among students in a team based learning for-
mat. Long-term plans for this course will incorporate the
other health related Schools on campus (Nursing, Dental,
health-related professions). School of Pharmacy faculty
have also developed a course to be offered in the third
professional year in collaboration with the Schools of
Medicine and Nursing. If approved, this proposed course
is structured to facilitate IPE opportunities and activities
will include standardized patient cases and simulation.
Introductory and Advanced Pharmacy Practice Experi-
ence activities throughout the curriculum are designed
to further foster interprofessionalism across inpatient
and outpatient practice settings.
The Northeast Ohio Medical University College of
Pharmacy has a very innovative interprofessional health
care education and research program; pharmacy and
medicine students learning together. The pharmacy
and medicine curricula integrates the 15 disease states
as core competency areas identified by the Institute of
Medicine (IOM) for all health care practitioners, as well
as topics that impact the health of Northeast Ohioans. The
curricula provides opportunities to develop and practice
skills as part of a team environment in multiple training
and clinical settings. The pharmacy course sequence is
based on curriculum year themes in which knowledge,
skills and experience build upon previous courses.
Year one focuses on dosage forms and gives students
an understanding of and the ability to: 1) select appropri-
ate dosage forms for a given situation, 2) research the
availability of dosage forms, and 3) compound individu-
alized dosage forms. Year two turns to medication use
systems and gives insight into pharmacy management
and personnel, dispensing medications safely and recog-
nizing the basic science related concepts that govern
selecting the correct dosage regimen and formulation
for the patient. Year three focuses on patient safety and
provides understanding of existing federal laws and their
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application in the practice setting. This year also focuses
on the ability to design the optimal therapeutic regimen
for a disease or situation and to monitor and report less
than optimal outcomes (adverse events, medication er-
rors, noncompliance, etc.) based on evidence-based med-
icine. The third year pharmacy students interact with
second year medical students in some coursework illus-
trating that matching professional years isn’t required and
offers opportunity for additional interprofessional over-
lap when appropriate topics can be timed together. Year
four turns to patient-centered care and offers direct pa-
tient care learning regarding decision-making and out-
comes of therapeutic management. Overall, there is an
optimal blend of coursework and experiential learning
that enables the students to learn, practice and be assessed
in a coordinated and timely fashion with focus on team-
work and interprofessionalism. The course content is
designed with the intent of revisiting diseases and medi-
cations each year, but with increasingly more complex
content in order to promote critical thinking.
Integration of the two curricula is extensive and in-
cludes seven didactic courses offered to learning with one
another. In the first two professional years the students
learn and work together during active learning in these
didactic offerings. The two college’s longitudinal experi-
ential learning sequences include numerous interprofes-
sional-learning activities throughout the program. All of
these activities focus on core competencies for interpro-
fessional teamwork at varying degrees. Taken in sum, the
overlap is significant between the two colleges and works
on an endpoint of better team-oriented outcomes as well
as a deep understanding of the importance of these ap-
proaches to maximize interprofessionalism.
The work of our faculty strengthens our nation’s
ability to address individual and population health prob-
lems through basic and translational research to im-
prove the quality of care delivery. Faculty engagement
in health services research improves the way in which
care is provided and identifies successful practice patterns
that include fair and equitable payment to team-based
practitioners. While the primary aim of this research is
to improve the public’s health, the results and recommen-
dations support scholarly teaching and the translation
of new knowledge that informs the work of other re-
searchers, scientists and practitioners. Combining the
scholarly work of faculty focused on health services re-
search allows academic institutions to bring the value of
this area of research to a broader audience.
TheUniversity ofSouthernCalifornia School ofPhar-
macy (USC) recently established the Leonard Schaeffer
Center for Health Economics and Policy in a unique
partnership with the USC Price School of Policy. This
Center, which serves as a combination research center,
“think tank”, and policy institute, combined the strengths
of the pharmacoeconomic and health services research
faculty in the School of Pharmacy, the health economist
and health policy faculty from the Price School of Policy,
and four additional health services and health economists
recruited from the Rand Corporation to create a uniquely
positionedCenter to conduct research, study, analyze, and
recommend and advocate for policy changes and serve as
an active “think tank” to develop new approaches to de-
livering health. As an example of what can be accom-
plished in a collaborative environment, the Schaeffer
Center faculty were awarded over $25 million in new
NIH grants in the first year of operation.
Other schools including theUniversity ofWashington,
the University of North Carolina at Chapel Hill, the Uni-
versity ofMinnesota, the University ofMaryland, Purdue
University, The University of Iowa, the University of
Wisconsin-Madison, and the University of Florida have
well-established doctoral and master’s programs aimed
at increasing the number of pharmaceutical health ser-
vices researchers. The international value of health ser-
vices research in general and pharmaceutical outcomes
research in particular led to the establishment of The In-
ternational Society for Pharmacoeconomics andOutcomes
Research (ISPOR), by pharmacy faculty, Dr. Joel Hay and
others.
Health service research includes clinically-driven
programs that focus on the outcomes of pharmacist in-
terventions in real-world practice. Now referred to as
patient-centered outcomes research, this type of health
services research strives to improve the quality of care the
outcomes and recommendations of which improve the
professional curriculum, increase the public expectation
of the pharmacist and provide payers with information
to move toward pay for performance based on science.
The University of Southern California and the University
of Minnesota have taken a leading role in the develop-
ment and implementation of a patient safety initiative
administered through the Health Resources and Services
Administration (HRSA) Office of Pharmacy Affairs.
Initiated through a demonstration project that partnered
colleges and schools of pharmacy with community health
centers, the Patient Safety andClinical PharmacyServices
Collaborative (the Collaborative) continues to improve the
quality of healthcare services provided to underserved pop-
ulations in our nation’s safety-net clinics and hospitals.
The ability of the Collaborative to use the concept of
rapid-cycle quality improvement and expert faculty con-
sultation to improve patient outcomes was identified as
a reason the Centers for Medicare and Medicaid have
asked Collaborative partners to work with the Quality
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Improvement Organizations in their state to improve the
quality of care for Medicare beneficiaries. The success of
these programs has been demonstrated with peer reviewed
published research anda number of clinical tools have been
developed for integration into the clinic settings.14
Researchers have incorporated and published their
experiences and outcomes of interprofessional experiences
in underserved settings. Some good examples include
student-run clinics from the University of California, San
Francisco, where interprofessional student teams care for
hepatitis B patients.15 The University of Florida provides
an Interdisciplinary Family Health course that emphasizes
community-based learning experiences. Underserved set-
tings may provide a good environment for interprofes-
sional education, with the HRSA collaborative serving as
one model.16
Proposed Suggestion
AACP member schools and individual faculty are
strongly encouraged to partner with local Federally
qualified safety net clinics and participate in the PSCPS
Collaborative to demonstrate further the value of clinical
pharmacy services, to expand the influence of clinical
pharmacy and to serve their local communities in under-
served settings.
Proposed Recommendation
AACP will develop an institute focused on [strate-
gies for identifying opportunities and reducingbarriers to]
interprofessional education in which interprofessional
teams shall attend.
Proposed Suggestion
AACP members are strongly encouraged to pro-
actively seek interprofessional education opportunities
as recommended by the Interprofessional Education Col-
laborative (IPEC) in their May report with campus and
community-based partners.
The Value of Education and Science Scholarship to
Communities
The United States healthcare system is influenced
and regulated by a number of federal agencies. These in-
clude the Centers for Medicare and Medicaid Services,
National Institutes of Health, Centers for Disease Control
and Prevention, Food and Drug Administration, Health
Resources and Services Administration and the Agency
forHealthcareResearch andQuality. These organizations
increasingly are focused on the implementation of the
provisions of the Patient Protection and Affordable Care
Act (PPACA).17 The intent of PPACA is to create a high
quality healthcare system that won’t bankrupt our nation
and that will provide improved health outcomes for our
citizens. Improving health, improving healthcare and re-
ducing costs provide the underlying quality improvement
strategies for this landmark legislation. And yet, these
strategies have been developing within the health policy
arena for decades and would have maintained their rele-
vance and traction even without PPACA. Uniformly, the
cost of care and the value we as a society gain from that
cost remain the important drivers for seeking a reorgan-
ized approach to health care delivery and a renewed com-
mitment to keeping individuals healthy and reducing the
impact of preventable illness.
The expression of these strategies is not sufficient
for reorganizing the delivery of healthcare. Implement-
ing these strategies is currently being accomplished by
grant support from a variety of federal agencies respon-
sible for acting on the intent of Congress as expressed in
PPACA. While the requests for proposals invariably re-
quest applicants to forward their most innovative ap-
proaches to addressing the stated proposal goals, it is
the traditional methods of grant review and advisory
committee recommendations that will put proposals into
action and continue refinement of research questions to
address this pressing public need.18 Our faculty are the
content experts for a wide-range of education and sci-
ence knowledge that is essential to the improvement of
our healthcare system. Faculty at AACP member insti-
tutions must increase their participation on these grant
review boards and advisory committees. To further future
health policy recommendations faculty must also seek
greater participation in the array of federal fellowship
opportunities that exist within agencies such as the Food
and Drug Administration, Centers for Disease Control
and Prevention and the National Institutes of Health to-
ward the end of sharing their science knowledge to in-
fluence public policy development and implementation
and increase their knowledge of what that public policy
is and how it should be integrated into the professional
curriculum.
To heighten the impact of pharmacy faculty exper-
tise on the development of public policy, the IOM within
the year, is expected to establish a Pharmacy Fellow to its
distinguished Fellows Program. The IOM interest com-
bines the organizations recognition of the contributions of
many academic pharmacy faculty and leaders that are
among its membership with the contributions of faculty
engaged in awide-array of programs supportive of federal
agencies. Pharmacy facultymake up a large portion of the
faculty for the HRSA Collaborative. The many advisory
committees of both the National Institutes of Health and
the Food and Drug Administration benefit from the in-
clusion of pharmacy faculty. Grant-awarding federal
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agencies also seek pharmacy faculty as members of their
grant review committees based on their knowledge and
skills.
Fortified with the teaching, research and service ex-
pertise of our faculty, our graduates are our primary input
into a reorganized healthcare system. Increasingly the
knowledge, skills and abilities of our graduates are recog-
nized as essential for addressing the triple aimof a reorgan-
ized health system. Former Surgeon General C. Everett
Koop is attributed with the quote, “Drugs don’t work if
patients don’t take them.” The growing recognition of
the negative impact on health and economic outcomes
associated with poor adherence to medication regimens
is just one of the opportunities for integrating pharmacists
into healthcare teams. The National Consumer League’s
public campaign, Script Your Future, is driving patients,
providers and care-givers to the pharmacist for structured
approaches for improving patient adherence.19
The Patient Centered Primary Care Collaborative
(PCPCC), a national collective of organizations created
for the development of tools and resources associated
with the creation of primary care medical homes (PCMH),
recognizes the importance managing medications.20 Com-
prehensive medication management, which includes the
assessment of a patient’s ability to remain adherent, sup-
ports the integration of the pharmacist into the primary care
team. The medication management resource developed by
the PCPCC states, “The current academic preparation of
pharmacists qualifies them to deliver medication manage-
ment services. All practicing pharmacists are capable of
providing this service, although additional training may
be required to meet the standards described in this docu-
ment. Many pharmacists now provide this service and are
being paid by federal and state governments and private
insurers. This service can no longer be considered a new
service. The service is scalable and can be delivered in
a PCMH when appropriate financial support exists in the
organizational structure.”
The PPACA provides additional opportunities for
the integration of the pharmacist across the healthcare
continuum. Provisions within the legislation include the
pharmacist in community-based healthcare teams, im-
proving care coordination and increasing medication rec-
onciliation access to patients moving between types of
care, and improving interprofessional health professions
education in federally supported area health education
centers andgeriatric education centers. To get us to amore
effective, efficient health system, the PPACA authorized
the creation of the Center for Innovation within the Cen-
ters for Medicare and Medicaid Services. The Center for
Innovation has already released several requests for in-
novative practices that alignwith andwill benefit from the
relationships and systems our faculty have been instru-
mental in establishing across the United States.
Like the evaluation and assessment of our programs
and curricula the evaluation and assessment of healthcare
delivery systems is an opportunity for faculty scholar-
ship. Broadening the implementation of these innovative
approaches and their evaluation provide continued en-
gagement for faculty and ultimately integration of our
graduates. The PPACA reflects the interest of health
and public policy analysts and advocates for a more rig-
orous approach to determining the effectiveness of ser-
vices. The Patient Centered Outcomes Research Institute
(PCORI) is a direct expression of that effectiveness
interest. Aligned with the comparative effectiveness
work of the Agency for Healthcare Research and Qual-
ity, PCORI, through the creation of a national research
agenda, establishes effective healthcare service delivery
as a national priority. That priority can and should be
influenced by pharmacy faculty. That influence is appro-
priate in light of AACP policy that states “AACP and
colleges/schools of pharmacy should promote pathways
of faculty development that enable pharmacy faculty
members, including non-tenure track faculty, to lead
and/or participate in practice-based, translational re-
search which was approved by the AACP House of
Delegates in 2008. Whether health services research is
undertaken in a comparative format, or utilizes some
other methodology, pharmacy faculty can and do contrib-
ute to the refinement of current services and the develop-
ment of more effective future services.
Improving Health
Improving the delivery of services is not the only
opportunity for our graduates and faculty. As discussed
earlier, our nation’s health outcomes do not positively
reflect the benefit of the trillions of dollars spent annually.
For decades, maybe centuries, the public policy of our
nation has failed to address population health through
sustained federal investment in disease prevention and
health promotion. Committing to a society of healthy in-
dividuals provided evidence-based clinical and popula-
tion interventions has proven difficult. The escalating
cost of care and the poor outcomes in terms of improved
health associated with those costs is driving a change in
health policy. That change is seen in many provisions of
the PPACA that mandate funding for the Prevention and
Public Health Fund and authorized grant funding for pro-
grams such as theCommunity PreventionGrants program
at the Centers for Disease Control and Prevention (CDC).
The health professions education community plays a
significant role in moving this public policy agenda
through the Healthy People Curriculum Task Force,
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an organization administered through theAssociation of
Prevention Teaching and Research. This group has cre-
ated an interprofessional clinical prevention and popu-
lation health curriculum and provided data for Healthy
People 2010 and 2020 objectives related to public health
education across the education spectrum.20
AACP member institutions are long-standing sup-
porters for the integration of public health into the phar-
macy professional curriculum. In 1994, the House of
Delegates passed a policy that states, “AACP supports
the development and implementation of curricular com-
ponents and associated instructional strategies which as-
sure a common set of core competencies and knowledge
concerning population-based epidemiology, the determi-
nants of health, effective programs in health promotion
and disease prevention, and primary health care services
delivery for all health professionals.” Approaches for cur-
ricular content development and implementation were
part of a successful practices call through the Association
of Prevention Teaching and Research in 2010. Six phar-
macy faculty successfully submitted case studies of their
clinical prevention and population health work which are
posted on the AACP website.22
Proposed Policy Statement
AACP will support member colleges and schools in
their efforts to develop and maintain strong, mutually
beneficial community-campus partnerships that demon-
strate and recognize the value of education and science
scholarship and innovative practice models that improve
the quality of individual and community health outcomes.
Addressing the Cost of Care
Direct impact reducing the cost of care can be ac-
complished through the development and evaluation of
innovative approaches to care that focus on value and
outcomes. Health professionals can be most effective in
reducing the health costs of individual patients when
service provision is undertaken through a lens of patient-
centeredness which includes the reduction of health dis-
parities, increasing access to evidence-based care, and the
provision of care that is culturally competent. This indi-
vidual patient approach to care is supported by AACP
policy passed by the House of Delegates in 2008 which
states “Colleges/schools of pharmacy should work to ad-
vance learners’ human cognition, ethical developments,
and behavior. Meaningful strategies include teaching and
assessing ethics, cultural competency, intra- and inter-
professional teamwork and community engagement with
underserved populations.”
It is important to bring attention to this statement’s
expectation of teaching and assessment as important
elements for evaluating the competence of future phar-
macists to provide this level of cost-conscious care. The
strength of that competence and ability to influence an
unwieldy health system requires a similar strength in ed-
ucation scholarship tomaximize didactic and experiential
experiences. Overall, healthcare costs can be impacted by
focusing on wellness and disease prevention and further
erosion of health status for the chronically ill. We know
that improving the management of medications associ-
atedwith the care of the chronically ill does have apositive
impact on overall health costs.23 What the most effective
approach to medication management is to gain this re-
duction is an essential research question for pharmacy
faculty and other health service researchers. This research
can then inform the professional curricula of all health
professions institutions so that patient-centered, team-
based care becomes a measurable reality.
Likewise, the recognition that the value we derive
from our current health expenditures provides some chal-
lenges in the context of improved health outcomes and
specifically public health measures such as life expec-
tancy, infant mortality and rates of chronic illness, has
supportedwellness anddisease preventionas a framework
for a reorganized health system. While the importance of
wellness and disease prevention is recognized, to whom
these interventions are provided can have substantial im-
pact on whether the conclusion can be drawn that pre-
vention does lead to overall savings.24 Like the delivery
of acute medical care, preventive services suffer from
a similar lack of evidence for their efficacy that is just
now being addressed and catalogued. That is why the
PPACA, in an effort to address this issue, requires the
U.S. Preventive Health Services Task Force to play a role
in establishing the evidence-base for the clinical preven-
tion and population health interventions.
Health professional understanding of the social, as
well as the physical andmental determinants of health can
significantly impact the cost of care. One way that aca-
demic pharmacy brings a level of cost-consciousness to
student pharmacists is through their engagement with un-
derserved populations. This engagement frequently in-
cludes experiences within the professional curriculum
including introductory professional practice experiences
(IPPE) or advanced professional practice experiences
(APPE). It also occurs through student-led projects, such
as those supported by the American Pharmacists Associa-
tionAcademy of Student Pharmacists or with other student
organizations. The benefits to the students and their com-
munities are recognized through theAACP Student Com-
munity Engaged Service Awards. The cost-sensitivity
impact on students of these activities have been demon-
strated through peer-reviewed publications, showing
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increased cultural competence in providing care to these
populations as well as beneficial effects to the community
in which the patients live.25-27
Long-term cost savings are anticipated from the
use of technology platforms to exchange healthcare in-
formation. The federal government continues to make
a significant investment into the development and
implementation of electronic health records and most
importantly, their meaningful use.27 Increasing the
health information technology (HIT) capacity of entire
communities and regions of the United States is being
addressed through the Beacon Communities program.
Several AACP member institutions are actively en-
gaged in these community-based HIT integration activ-
ities. As important as development and integration of
these potential cost-saving programs are, of greater im-
portance is the understanding and capacity of health
professionals to access and effectively utilize the large
amounts of patient-level data that are made available
through HIT.
AACP member institutions are committed to im-
proving the communication skills of our graduates. A
policy statement approved by the AACP House of Dele-
gates in 2008 states that, “AACP and colleges and schools
of pharmacy should assure that students, faculty and
alumni have sophisticated and continuous preparation in
the design and use of health information technology (HIT)
and systems and are prepared to apply HIT evidence-
based decision-making at the point of patient care. Yet,
this policy statement is not overt in its expectation that
students, faculty and alumni are able to effectively and
efficiently make better decisions based on the evidence-
based presented through HIT. In fact, the amount of in-
formation may result in the opposite. A recent HIT study
found that physicians confronted with information in an
electronic health record are more likely, not less, to re-
order x-rays even though the record indicates that x-rays
have already been ordered and the results available.28
This clearly indicates that the cost-saving benefits of
HIT will not be realized until health professions students
are educated and competent to analyze the wealth and
maybe overload of information made available through
HIT. To date, the consideration of health professions ed-
ucation as an important component for HIT cost-benefit
realization has not been a significant aspect of public
policy development.30
Addressing the Charge Through the Creation of
a Public Policy Framework
To better articulate the importance of:
1. rebalancing the science and education scholar-
ship portfolios;
2. sharing with the public the importance and rel-
evance of the contributions of academic phar-
macy; and
3. getting beyond the real and perceived barriers
to strong interprofessional education oppor-
tunities. . .
. . .we provide a policy framework to guide the on-
going work of our Academy to protect the public health
through the education of the pharmacist,meet the needs of
an ever-changing society through the research of our fac-
ulty, and engage with our communities and partners to
translate new knowledge into service interventions that
increase the quality of life for individuals here in the
United States and around the world.
AACP Policy Agenda
The mission of pharmacy education is to prepare
graduates who provide patient-centered care that ensures
optimal medication therapy outcomes and provides a
foundation for specialization in specific areas of phar-
macy practice; participation in the education of patients,
other healthcare providers, and future pharmacists; con-
duct of research and other scholarly activity; and provi-
sion of service and leadership to the community. (Source:
Academic Affairs Committee, 2007) This mission is crit-
ical for the protection of the public health and the assur-
ance that pharmacist graduates are competent to meet
state regulatory requirements as stated in individual state
practice acts.
Discover, Learn, Care. . .ImproveHealth. As the tag-
line of theAmericanAssociation ofColleges of Pharmacy
states, our members meet the mission of pharmacy edu-
cation through the mission of higher education teaching,
research, service, which are all focused toward the end of
improving health. Improving health by focusing on indi-
vidual and population health is one of the three elements
of the “triple aim” of a reorganized healthcare system.31
The other two elements are improving healthcare to im-
prove the patient experience and controlling costs through
cost-avoidance strategies.
Academic pharmacy and all of health professions
education, does and should contribute to improvements
in individual and population health. As an organization,
AACP will influence public policy so our members are
able to:
Improve Health
As a nation we spend more per capita than any coun-
try in the world and have health outcomes for some public
health indicators that are worse than some of the world’s
least developed nations. The cost of chronic illness is
bankrupting Medicare, creating an overwhelming onus
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on primary care providers and negatively impacting fam-
ilies, communities and business in lost productivity, lost
days in schools and poor care coordination. Academic
pharmacy will work to improve the health of individuals
and populations so that our nation’s leading health indi-
cators reflect a healthy, productive population through:
Teaching. Engage in evidence-based learning strat-
egies that integrate the concepts of clinical prevention
and population health into the professional curriculum.
Strengthen the competence of pharmacy students to
provide evidence-based clinical prevention and popula-
tion interventions as members of a healthcare team.
Research. Engage in scholarly activity that im-
proves the evidence-base of clinical prevention and pop-
ulation health interventions.
Service. Provide clinical prevention and population
health interventions that are evidence-based and support
the whole patient and not just an individual with the ab-
sence or presence of disease.
AACPPolicy.AACP supports the development and
implementation of curricular components and associ-
ated instructional strategies which assure a common
set of core competencies and knowledge concerning
population-based epidemiology, the determinants of
health, effective programs in health promotion and dis-
ease prevention, and primary health care services deliv-
ery for all health professionals. (Source: Professional
Affairs Committee, 1994)
Improve Healthcare
Recognizing that we receive poor value in terms of
health outcomes and quality compared to many other na-
tions, the quality chasm has been the subject of numerous
reports published by the Institute of Medicine. The “qual-
ity series” of the Institute of Medicine, way back in 2003,
recommended that we educate healthcare professionals
competent to deliver patient-centered, team-based care,
supported by informatics, in order to improve the quality
of care patients receive. Academic pharmacy will work
to close the quality chasm and support innovative ap-
proaches to health systems reorganization through:
Teaching. Engage in evidence-based learning
strategies that provide students with the necessary skills
and knowledge to provide patient-centered, team-based
care, supported by effective and meaningful use of in-
formatics and committed to quality improvement (IOM
2003).
Advance the quality of health professions education
including interprofessional and culturally competent ap-
proaches by enhancing curricula and courses to reflect the
current state and continual changes in healthcare through
regular assessment.
Research.Advance the concepts of team-based care
through use of a scholarly approach to interprofessional
education and the development of successful practices
grounded in evidence-based higher education theory.
Continue to develop, refine, implement and dissem-
inate successful practices focused on student achievement
and progress and competencies associated with educa-
tional outcomes and accreditation standards.
Strengthen our nation’s ability to address individual
and population health problems by engaging in basic re-
search to cure disease, translational research to improve
the quality of care delivery, and health services research
to improve the way in which care is provided and deter-
mine successful practice patterns that include fair and
equitable payment to team-based practitioners.
Service. Participate in federal, state and local ef-
forts aimed at improving healthcare delivery systems
including those forthcoming from the CMS Center for
Innovation, HHS Office of the National Coordinator
(HIT) and HRSA Patient Safety and Clinical Pharmacy
Services Collaborative.
AACPPolicy.Colleges/schools of pharmacy should
work to advance learners’ human cognition, ethical de-
velopments, and behavior. Meaningful strategies include
teaching and assessing ethics, cultural competency, intra-
and inter- professional teamwork and community engage-
ment with underserved populations. (Source: Board of
Directors based on Argus Commission, 2008)
AACP and colleges and schools of pharmacy should
assure that students, faculty and alumni have sophisti-
cated and continuous preparation in the design and use
of health information technology (HIT) and systems and
are prepared to apply HIT in evidence-based decision-
making at the point of patient care. (Source: Board of
Directors based on Argus Commission, 2008)
AACP supports and encourages the implementation
of on-going program assessment processes at member
institutions for the purpose of enhancing the quality of
educational programs and student services. (Source: Ac-
ademic Affairs Committee, 2004)
AACP supports interdisciplinary and interprofes-
sional education for health professions education. (Source:
Professional Affairs Committee, 2002)
Control Costs
Patient, providers and payers must all work together
to ensure that the healthcare services that are provided
reflect an appropriate balance of scientific-evidence and
recognition of patient-centeredness so that unnecessary
costs are avoided and health outcomes are maximized.
Academic pharmacy will engage in actions that will in-
crease the value of healthcare through:
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Teaching. Engage in evidence-based learning
strategies that prepare pharmacy students to be aware
of the: cost impact of their actions; evidence-based
guidelines to align health outcomes with cost; opportu-
nities to improve the quality of care through quality
performance measures; advocate for practice changes
that can reduce the cost of care without decreasing care
quality; utilization of information systems; and pro-
cesses that support cost avoidance such as adverse event
reporting.
Research. Engage in scholarly activity that seeks to
improve the capacity of health information technology to
effectively and efficiently input quality performance mea-
sures that can lead to cost avoidance or cost reductions.
Engage in scholarly activity that evaluates the real
and expected impact of health and economic outcomes
associated with quality performance measures.
Engage in scholarly activity that contributes to and
evaluates the evidence used to develop practice guidelines.
Service. Prepare faculty and preceptors to present as
role models the utilization of quality improvement and
cost avoidance strategies in which they endeavor to in-
culcate within pharmacy students.
AACP Policy. Research that explores the social,
economic, organizational and clinical factors that influ-
ence the outcomes of drug therapy in prevention or treat-
ment of disease should be central to the mission of all
colleges/schools of pharmacy. (Source: Educating Clini-
cal Scientists Task Force, 2008)
CONCLUSION
Looking back on the charges given to this committee
by President Crabtree it appears that AACP as an orga-
nization and its individual members and institutions
highly regard education scholarship. That regard is readily
expressed in the programs, products and services developed
in an effort to continually improve the quality of pharmacy
education. The implied importance of quality should be
more explicitly expressed in at least a policy statement
reflecting the Academy’s commitment to the important
public policy issue of quality in higher education. In this
way, the actions are balanced with the thoughts of the
Academy. Improving the quality of pharmacy education
requires a new commitment to education scholarship at
a level that eliminates the comparison of teaching-intensive
and research-intensive institution from the vocabulary
of pharmacy faculty. There are still way too many unan-
swered questions regarding how to improve the quality
of education for any faculty member to not engage in
some form of new knowledge creation in regard to
education.
The many policy statements in support of science
scholarship must be balanced in a similar manner. Our
programs, products and services related to the improve-
ment of science scholarship must align with our policy
statements. The entire Academy must engage in science
scholarship at a level that begins to balance our actions
with our statements. As is true for education scholarship,
science scholarship, particularly health services research,
should be a scholarly activity of every clinical faculty
member. The public policy benefit of this type of research
is limitless and does not require extensive research labo-
ratory support. The third aspect of the mission of higher
education, service, benefits from this attention to both
education and science scholarship. The intervention of
our faculty and students into the issues communities de-
fine as important and worthy of partnership require an
academic commitment to scholarly service. In this way
the community perception of true engagement can be met
and maintained.
The public expectation that the graduating pharma-
cist is competent to protect their personal and population
well-being is sustained through the continuous improve-
ment of that graduate’s educational experience. The
economic value of a school of pharmacy to a community
can and has been described.32 Yet, it is the value to
improved healthcare quality, improved health and con-
tainment of health costs that best demonstrate the value
of a school of pharmacy to a community. The members
of this committee believe that describing the value as
stated above should be a goal of every college and school
of pharmacy in the nation. Continuously improving the
quality of pharmacy education through the creation of
new knowledge and the integration of that new knowl-
edge back into the professional curriculum sustains the
trust the public places in the pharmacist.33 Translating
new knowledge into the practice settings of the many
community-service activities of our students and faculty
continually improves the public perception of the Acad-
emy and the profession. The ability of pharmacy educa-
tion to help communities meet their identified challenges
is the best demonstration of the Academies value to that
community.
Improving the quality of education cannot be a soli-
tary pursuit. Public policy and community challenges
cannot be addressed by a single individual or profession.
The capacity of any individual is limited and the expec-
tations of communicating new knowledge to advance pa-
tient and population health appears limitless. Therefore,
academic pharmacy must maintain its commitment to
collaboration and interprofessional education and re-
search. Again, while the economic argument brings value
to the expression of this commitment, it is the improved
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healthcare, improved health and the containment of
health costs that prove the real value to individual patients
and communities. Shared accountabilities and shared re-
sources can strengthen the public perception of academic
pharmacy as a trusted community partner to develop and
evaluate both policy and clinical interventions that meet
community needs today and tomorrow.
AACP and its member institutions and faculty are
actively engaged in improving the quality of pharmacy
education. We are already engaged in the strategies that
make academic pharmacy a trusted and valued commu-
nity partner. We are already engaged in the strategies
that will make interprofessional education the best way
of improving healthcare, improving health and contain-
ing costs. The examples in this report and the many
others not included provide ample demonstration of
the Academies undertaking of strategic partnerships to
maintain the public trust and create and translate new
knowledge into the partnerships that depend on that
trust. Therefore, using the mission of higher education
as refined in the AACP tagline, Discover, Learn,
Care. . .Improve Health, AACP and its member institu-
tions and faculty can continually improve public policy
not just today, but long into the future.
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